Sammanfattning
Increased expression of endothelin receptor type B (ETBR), a vasoactive receptor, has recently been implied in the reduced cerebral blood flow and exacerbated neuronal damage after ischemia-reperfusion (I/R). The study explores the regulatory mechanisms of ETBR to identify drug targets to restore normal cerebral artery contractile function as part of successful neuroprotective therapy.
Originalspråk | engelska |
---|---|
Artikelnummer | e113624 |
Tidskrift | PLoS ONE |
Volym | 9 |
Nummer | 12 |
DOI | |
Status | Published - 2014 |
Ämnesklassifikation (UKÄ)
- Annan klinisk medicin